{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1285"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Controlled Substances Act to make any\n\t\t  substance containing hydrocodone a schedule II drug."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130320", "#text": "March 20, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on\n\t\t\t the ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, {"#tail": ", for a\n\t\t\t period to be subsequently determined by the Speaker, in each case for\n\t\t\t consideration of such provisions as fall within the jurisdiction of the\n\t\t\t committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}], "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Buchanan", "@name-id": "B001260"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Markey", "@name-id": "M000133"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Capito", "@name-id": "C001047"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Diaz-Balart", "@name-id": "D000600"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Duncan of Tennessee", "@name-id": "D000533"}, {"#tail": ", ", "#text": "Mr. Mica", "@name-id": "M000689"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Roe of Tennessee", "@name-id": "R000582"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rogers of Kentucky", "@name-id": "R000395"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rooney", "@name-id": "R000583"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Ros-Lehtinen", "@name-id": "R000435"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Brown of Florida", "@name-id": "B000911"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Cooper", "@name-id": "C000754"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Edwards", "@name-id": "E000290"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Hastings of Florida", "@name-id": "H000324"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Keating", "@name-id": "K000375"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Lynch", "@name-id": "L000562"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rahall", "@name-id": "R000011"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Wilson of Florida", "@name-id": "W000808"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Kennedy", "@name-id": "K000379"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Murphy of Florida", "@name-id": "M001191"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Castor of Florida", "@name-id": "C001066"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. DesJarlais", "@name-id": "D000616"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Fincher", "@name-id": "F000458"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Miller of Florida", "@name-id": "M001144"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Nugent", "@name-id": "N000185"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Tiberi", "@name-id": "T000462"}, {"#tail": ", ", "#text": "Mr. Issa", "@name-id": "I000056"}, {"#tail": ", ", "#text": "Mr. Deutch", "@name-id": "D000610"}, {"#tail": ", ", "#text": "Mr.\n\t\t\t Posey", "@name-id": "P000599"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Black", "@name-id": "B001273"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Pearce", "@name-id": "P000588"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Marino", "@name-id": "M001179"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Slaughter", "@name-id": "S000480"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Westmoreland", "@name-id": "W000796"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Stivers", "@name-id": "S001187"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Benishek", "@name-id": "B001271"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Crenshaw", "@name-id": "C001045"}, {"#tail": ", ", "#text": "Mr. Ross", "@name-id": "R000593"}, {"#tail": ", ", "#text": "Mr. Higgins", "@name-id": "H001038"}, {"#tail": ", ", "#text": "Mr.\n\t\t\t Southerland", "@name-id": "S001186"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Tipton", "@name-id": "T000470"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Shuster", "@name-id": "S001154"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Miller of Michigan", "@name-id": "M001150"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Rodney Davis of Illinois", "@name-id": "D000619"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Schock", "@name-id": "S001179"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H5053C6D58BD94732BD07C1A4A1C3AAC7", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Hydrocodone\n\t\t\t amendment"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Schedule III(d) in\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t by\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/812", "#text": "21 U.S.C. 812", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Controlled Substances Act/s:202/p:3"}, {"#tail": "; and", "@entity-type": "act", "#text": "(4)", "@value": "Controlled Substances Act/s:202/p:4"}], "#text": "striking ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HB3F094DE09264E63BFDB26F6E70E4037", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "paragraphs (5), (6), (7), and\n\t\t\t (8)", "@value": "Controlled Substances Act/s:202/p:5,6,7,8"}, {"#tail": ", respectively.", "@entity-type": "act", "#text": "paragraphs (3), (4), (5), and (6)", "@value": "Controlled Substances Act/s:202/p:3,4,5,6", "@proposed": "true"}], "#text": "redesignating ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H3BD18BDC4D464BFFBF0D43AB5D2FE291", "#text": "\n          "}], "#text": "\n        ", "@id": "HCDBE11CD53D3465F8A3E3E2E4729C27B"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall take effect on\n\t\t\t the date that is 6 months after the date of enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)", "@value": "113 HR 1285/s:1/ss:a", "@proposed": "true"}, "#text": "The amendments made by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "HC80D098BF72044739952FAAE5BA22C95"}], "#text": "\n      ", "@id": "HAE84EA22D64A40F39FBCE51322182962"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 1", "@value": "113 HR 1285/s:1", "@proposed": "true"}, {"#tail": " shall immediately,\n\t\t\t without regard to ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "Notwithstanding\n\t\t\t the amendments made by ", "external-xref": {"#tail": " of title 5, United States Code, amend section\n\t\t\t 1301.72 of title 21, Code of Federal Regulations, relating to the physical\n\t\t\t security controls for non-practitioners, narcotic treatment programs and\n\t\t\t compounders for narcotic treatment programs, and storage areas for controlled\n\t\t\t substances, to allow, for the 3-year period beginning on the date of enactment\n\t\t\t of this Act, manufacturers and distributors to store hydrocodone compound\n\t\t\t products in accordance with the physical security requirements for schedule\n\t\t\t III, IV, and V controlled substances.", "@parsable-cite": "usc-chapter/5/5", "#text": "chapter 5", "@legal-doc": "usc-chapter"}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Physical security\n\t\t\t requirements"}, "#text": "\n      ", "@id": "HB7F1B90519D9485CB23C23FD12614A22"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "GAO\n\t\t\t report"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to ", "@entity-type": "federal-body", "#text": "Comptroller General of the\n\t\t\t United States", "@entity-id": "0500"}, {"#tail": " a report on the reclassification of\n\t\t\t hydrocodone products under this Act.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than 18\n\t\t\t months after the date of enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "#text": "\n        ", "@id": "H7C2E3A587D904B51A722E2823E0BB85A"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "113 HR 1285/s:3/ss:a", "@proposed": "true"}, "#text": "The\n\t\t\t report required under "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Contents"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "an assessment of\n\t\t\t the degree to which the reclassification of hydrocodone products under this Act\n\t\t\t impacts the ability of patients with legitimate medical needs, particularly\n\t\t\t those in rural areas and nursing home facilities, to access adequate pain\n\t\t\t management; and"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H5A9F4748FC234E6CBF663C7CD2EA456D", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "recommendations\n\t\t\t necessary to address issues, if any, relating to patient access to adequate\n\t\t\t pain management."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HFB3D55624EC24752861E876292895E6B", "#text": "\n          "}], "#text": "\n        ", "@id": "H1D45520BFA5A479B8C89BBEE7F77F8FF"}], "#text": "\n      ", "@id": "H372016F4F7B74037BE41276FC541AEBD"}], "#text": "\n\t\t", "@id": "H64ADA54580D54D5781521F3E9A680C6C"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-20"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1285 IH: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug."}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}